Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes

Clinical Nuclear Medicine

Volumn 31, Issue 11, 2006, Pages 721-723

  Inoue, Kentaro ^a   Okada, Ken ^a   Harigae, Hideo ^b   Taki, Yasuyuki ^a   Goto, Ryoi ^a   Kinomura, Shigeo ^a   Kato, Shunsuke ^b   Kaneta, Tomohiro ^c   Fukuda, Hiroshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marrow; FDG; MDS; Myelodysplastic syndrome; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CASE REPORT; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG UPTAKE; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; POSITRON EMISSION TOMOGRAPHY;

AGED; BONE MARROW; BONE MARROW NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 33750364304     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000242685.55001.67     Document Type: Article

References (12)

1. Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood. 1998;91:3340-3346.
2. Chiang SB, Rebenstock A, Guan L, et al. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging. Clin Nucl Med. 2003;28:674-676.
3. Abe K, Sasaki M, Kuwabara Y, et al. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med. 2005;19:573-579.
4. Lewanski CR, Kaplan GR, Potter J, et al. Bone marrow involvement in breast cancer detected by positron emission tomography. J R Soc Med. 1999;92:193-195.
5. Yao WJ, Hoh CK, Hawkins RA, et al. Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. J Nucl Med. 1995;36:794-799.
6. Hollinger EF, Alibazoglu H, Ali A, et al. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med. 1998;23:93-98.
7. Sugawara Y, Fisher SJ, Zasadny KR, et al. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol. 1998;16:173-180.
8. Kazama T, Swanston N, Podoloff DA, et al. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging. 2005;32:1406-1411.
9. Blodgett TM, Ames JT, Torok FS, et al. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med. 2004;29:161-163.
10. Plantade A, Montravers F, Selle F, et al. Diffusely increased F-18 FDG uptake in bone marrow in a patient with acute anemia and recent erythropoietin therapy. Clin Nucl Med. 2003;28:771-772.
11. Takalkar A, Yu JQ, Kumar R, et al. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography. Clin Nucl Med. 2004;29:637-639.
12. Burrell SC, Fischman AJ. Myelofibrosis on F-18 FDG PET imaging. Clin Nucl Med. 2005;30:674.